Craft

Indivumed

Total Funding

$48 M

Revenue

€13 M

FY, 2020

Indivumed Summary

Company Summary

Overview
Indivumed is an oncology company developing individualized cancer therapy. It leverages the world’s multi-omics oncology database and biobank to research cancer. The company focuses on the generation, characterization, and analysis of biological samples from human cancer patients.
Type
Private
Status
Active
Founded
2002
HQ
Hamburg, DE | view all locations
Website
https://www.indivumed.com/
Cybersecurity rating
Sectors

Key People

  • Susanne Arbogast, Chief Medical Officer

  • Hartmut Juhl
  • Nils Clausnitzer

    Nils Clausnitzer, Chief Operating Officer and Head of IndivuServ Business Unit

LocationsView all

2 locations detected

  • Hamburg, HH HQ

    Germany

    Falkenried 88

  • Frederick, MD

    United States

    7210 Corporate Ct ste. e

Indivumed Financials

Summary Financials

Revenue (FY, 2020)
€13.0M
Gross profit (FY, 2020)
€4.8M
Net income (FY, 2020)
(€21.2M)
Cash (FY, 2020)
€6.4M

Footer menu